Usana Health Sciences' third-quarter profit skidded nearly 28 percent as the maker of nutritional supplements fought a shareholder bid led by former CEO Myron Wentz to take it private.
Usana earned $8.1 million, or 50 cents a share, compared with net income of $11.3 million, or 68 cents per share, a year earlier. Analysts surveyed by Thomson had been expecting 60 cents per share.
